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Background. Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite
advances in therapy and prognosis. The southeastern United States is a rapidly growing Latino settlement area where
ethnic disparities may contribute to late presentation to care.
Methods. We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care
initiation in the University of North Carolina Center for AIDS Research Clinical Cohort. We identified independent
predictors of late presentation, defined as a CD41 T lymphocyte (CD4) count,350 cells/mm3 or an AIDS-defining
event (ADE), using log-linear binomial regression.
Results. During the period 1999–2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were
white, and 61% were black. Median initial CD4 counts were lower for Latino patients (186 cells/mm3) than white
patients (292 cells/mm3; P 5 .006) and black patients (302 cells/mm3; P 5 .02). Latino persons were more likely to
be late presenters than white or black persons (76% vs 58%; P, .001) and accounted for 86%, 75%, and 50% of all
presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively. Latino ethnicity, older age,
male sex, and earlier entry year were independently associated with late presentation (P , .05 for all). In
multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons
(95% confidence interval, 1.15–1.45).
Conclusions. Latinos are more likely to initiate HIV care later in the course of illness than are black and white
persons and account for a majority of several ADEs. Strategies to improve earlier HIV testing among Latinos in new
settlement areas are needed.
The importance of early diagnosis of human immuno-
deficiency virus (HIV) infection is highlighted by the
profound reductions in morbidity and mortality with
the receipt of highly active antiretroviral therapy
(HAART) [1, 2] as well as the decreased opportunity for
onward HIV transmission. Unfortunately, presentation
late in the course of infection remains common [3, 4].
The epidemiology of HIV infection in the United States
is also characterized by significant racial and ethnic
disparities. US surveillance data from 1996 to 2005 in-
dicated that 42% of Latino persons develop AIDS #1
year after diagnosis of HIV infection, compared with
39% of black persons and 37% of white persons [3].
However, these small national differences may not fully
reflect the epidemiology of HIV infection among La-
tinos in specific regions because of the heterogeneity of
the Latino population, which is the fastest growing US
minority group, with origins in .20 countries. Nota-
bly, HIV risk behaviors, diagnostic rates, and interval
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progression from HIV diagnosis to AIDS among Latinos differ
by country of birth [5].
Nontraditional Latino settlement areas, such as the south-
eastern United States, have seen rapid Latino population growth
over the past 20 years [6, 7]. North Carolina experienced a 394%
increase in the Latino population from 1990 to 2000 [6] and had
the seventh largest population of Mexican-born immigrants
among all US states in 2008 [8]. Latinos residing in rapid-growth
southern states are more likely to be male, young, and foreign
born and to have arrived in the United States after 1995, com-
pared with states with long-established Latino communities,
such as California and New York [6]. This population may be at
increased risk for HIV infection because recent immigrants may
lack social support systems and stable sexual networks that are
found in traditional settlement areas [9]. Interrelated barriers to
HIV prevention, such as culture, migration, poverty, and limited
use of English [10], likely also influence testing and timing of
presentation to care.
Understanding disparities at initial entry to HIV care among
Latinos or other racial/ethnic groups in areas of rapid Latino
growth is important to develop directed public health inter-
ventions. We compared demographic characteristics, trans-
mission risk behaviors, and clinical factors among Latinos and
non-Latinos at first presentation to HIV care in a nontraditional
Latino settlement area and evaluated potential factors associated
with late presentation to HIV care.
METHODS
Patients and Design
We performed a cross-sectional evaluation of adults and ado-
lescents naive to HIV care who initiated HIV care for the first
time during the period from 1 January 1999 through 31 De-
cember 2009 at the University of North Carolina (UNC) In-
fectious Diseases Clinic, located in a large, tertiary care facility in
central North Carolina, and who participated in the UNC Center
for AIDS Research HIV Clinical Cohort (UCHCC). An estimated
98% of HIV-infected patients in the clinic participate in the
UCHCC, providing an accurate representation of the HIV clinic
population. To enroll in the UCHCC, participants must be aged
$18 years andmust provide written informed consent in English
or Spanish. Adolescents who enter care in the clinic can enroll in
the UCHCC when they reach 18 years of age. This study was
approved by the UNC Biomedical Institutional Review Board.
Variables
Demographic, risk behavior, and clinical data were abstracted
from medical records. The UCHCC has standardized data ex-
traction methods from medical charts and institutional data-
bases, as described elsewhere [11]. Medical information,
including the earliest date of HIV-positive test results and prior
illnesses, were extracted from UNC. Charts were reviewed to
ensure accuracy of race/ethnicity data in our medical records.
Geographic area of residence at entry was estimated using the zip
code approximation of Rural-Urban Commuting Area Codes,
a 2000 census-tract classification that uses urbanized area/cluster
definitions of core population size with work commuting in-
formation to determine rural and urban status [12, 13].We placed
patients in 3 categories: urban, large rural/town (‘‘micropolitan’’),
or small and isolated rural. Driving distances to clinic were es-
timated by calculating the distance from UNC to the centroid
of patient residence zip codes using CDX Zipstream and
Microsoft MapPoint 2010 software (Microsoft). HIV trans-
mission risk groups were categorized as men who have sex with
men (MSM), heterosexual, injection drug user (IDU), and
persons with other or unknown risk. Patients who could be
categorized as both IDU and MSM or as IDU and heterosexual
were categorized as IDU.
Outcomes and Definitions
Primary outcomes were the CD41 T lymphocyte (CD4) count,
obtained closest to and within 90 days of entering care at UNC,
and AIDS-defining events (ADEs) at entry. We defined late
presenters as patients who had CD4 counts ,350 cells/mm3 or
ADEs [14]. The subset of these patients who had CD4 counts
,200 cells/mm3 or ADEs at entry were defined as advanced
presenters. Advanced presenters whose first HIV-positive test
results occurred ,6 months before entry to HIV care were
classified as delayed testers. HIV RNA loads were only included
if available within 90 days of entry to care and within 2 weeks
after commencement of HAART. The ADEs were categorized on
the basis of the Centers for Disease Control and Prevention 1993
classification system [15] and included conditions diagnosed
#60 days after study entry.
Statistical Analyses
Differences in categorical variables by race/ethnicity and sex
were examined with the Pearson’s v2 test, and continuous var-
iables were evaluated with the Kruskal-Wallis test. We calculated
unadjusted prevalence ratios (PRs) and associated 95% confi-
dence intervals (CIs) for the prevalence of late presentation by
race/ethnicity, as well as other possible predictors of late care
presentation. Multivariable analyses were fit using log-linear
binomial regression to identify independent predictors of late
presentation. We first fit a full model based on results of our
bivariable analyses and then used backwards elimination to ar-
rive at a final model that included only factors predictive of late
care presentation on the basis of a 2-sided a of .05. We evaluated
the following possible predictors in addition to race/ethnicity:
age, sex, distance to care, urban/rural residence, transmission
risk group, and year entering care. PRs were calculated instead of
odds ratios to avoid overestimation of the relative risk because
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our outcome was common (.10%) [16]. All data were analyzed
using SAS software, version 9.2 (SAS Institute).
RESULTS
We identified 1256 patients who entered HIV care for the first time
during the period from 1 January 1999 through 31 December 2009, of
whom 876 had their entry to care at UNC and thus had compre-
hensive initial data for analysis. Twenty-three patients were then ex-
cluded because of unknown race or a race/ethnicity other than black,
white, or Latino. Our analysis was performed on these 853 patients, of
whom 61% were black, 28% were white, and 11% were Latino, with
a median age of 36 years. The 380 patients who had initiated care
outside of the UNC system had similar demographic characteristics,
although only 5% of these patients were Latino. Among the 853 pa-
tients in the analysis cohort, we did not find statistically significant
differences in the racial/ethnic composition over the 11-year period;
however, there were significant differences among these groups with
respect to demographic characteristics and transmission risk at entry to
care (Table 1). Latinos were significantly more likely to be younger
than black and white persons, with a median age of 30 years (inter-
quartile range [IQR], 26–37 years) for Latinos versus 36 years (IQR,
28–45 years) for black persons (P , .001) and 40 years (IQR, 30–46
years) for white persons (P , .001). More than 80% of patients
entered care within 6 months of their reported date of diagnosis of
HIV infection; however, black persons were more likely to have de-
layed entry by.6 months than were nonblack persons (20% vs 13%;
P 5 .01). Black persons and Latinos had a similar breakdown of
transmission risk group, with heterosexual risk predominating
(54% and 60%, respectively), which differed significantly from white
persons, among whom MSM risk predominated (53%; overall P ,
.001). Although the majority of our cohort resided in urban areas
(64%), Latinosweremore likely than black andwhite persons to live in
rural areas (48%; overall P 5 .02).
Table 1. Demographic and Risk Behavior Characteristics of HIV-Infected Individuals Entering HIV Care Between 1999 and 2009
Race/ethnicity
Variable Latino White Black P a
No. (%) of subjects 97 (11) 236 (28) 520 (61)
Year entering care .06
1999–2001 31 (32) 72 (31) 209 (40)
2002–2005 31 (32) 83 (35) 169 (33)
2006–2009 35 (36) 81 (34) 142 (27)
Median age, years b,c,d (IQR) 30 (26–37) 40 (30–46) 36 (28–45) ,.001
Median year of diagnosis c,d (IQR) 2003 (2001–2006) 2003 (2000–2006) 2002 (2000–2005) .002
Time from diagnosis to entry d .04
,6 months 86 (89) 204 (86) 418 (80)
$6 months 11 (11) 32 (14) 102 (20)
Sex c,d .002
Male 74 (76) 179 (76) 336 (65)
Female 23 (24) 57 (24) 184 (35)
Residence b,c .02
Urban 51 (52) 163 (69) 329 (63)
Large rural city/town 31 (32) 56 (24) 151 (29)
Small and isolated rural 15 (16) 17 (7) 40 (8)
Distance to clinic, km b,c ,.001
,97 (60 miles) 86 (89) 163 (69) 342 (66)
$97 (60 miles) 11 (11) 73 (31) 178 (34)
Transmission risk group b,c,d ,.001
Heterosexual 58 (60) 85 (36) 279 (54)
MSM 31 (32) 126 (53) 154 (30)
IDU 2 (2) 19 (8) 60 (11)
Other/unknown 6 (6) 6 (3) 27 (5)
NOTE. Data are no. (%) of patients, unless otherwise indicated. IQR, interquartile range; MSM, men who have sex with men; IDU, injection drug user.
a P values reflect Pearson’s v2 test results among all groups and categories.
b Statistically significant difference (P , .05) between Latino and white subjects.
c Statistically significant difference (P , .05) between Latino and black subjects.
d Statistically significant difference (P , .05) between white and black subjects.
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Generally, Latinos presented with more advanced HIV than
did white or black persons, but there were substantial differences
for men and women in all racial/ethnic groups; therefore, we
present results stratified by sex (Table 2). The overall median
CD4 count at HIV care initiation was 286 cells/mm3 (IQR, 63–
482 cells/mm3); it was significantly lower for Latinos, at 186 cells/
mm3 (IQR, 57–340 cells/mm3), compared with 292 cells/mm3
(IQR, 86–496 cells/mm3) for white persons (P 5 .006)
and 302 cells/mm3 (IQR, 56–505 cells/mm3) for black persons
(P5 .02). Latinos were more likely to be late presenters, but no
difference was seen between groups in advanced presenter
status. These trends in late presentation are largely due to dif-
ferences among men. Latino men were significantly more likely
than white and black men to be late presenters (both P5 .001)
and were also significantly more likely than black men to be
advanced presenters (P 5 .03) and to have an ADE (P 5 .02)
(Table 2). Latinas were not significantly different than black or
white women in any of the aforementioned clinical character-
istics, although Latinas were more likely to be pregnant at the
time of entry (overall P , .001). Pregnant women had higher
median CD4 cell counts (430 cells/mm3) than nonpregnant
women (313 cells/mm3; P 5 .002) or men (254 cells/mm3;
P , .001). However, pregnant Latinas had lower median CD4
counts than did pregnant non-Latinas (361 vs 461 cells/mm3;
P 5 .09). Although no statistically significant differences
among groups were seen among delayed testers overall, fewer
black women were delayed testers, compared with white
women. Viral loads also differed marginally among the racial/
ethnic groups but were substantially different between sexes.
In unadjusted analyses, Latino ethnicity, older age, male sex,
and earlier calendar year of entry were associated with late
presentation (Table 3). All of these variables remained in-
dependent predictors in the multivariable regression model,
which was adjusted for all variables. Latinos (PR, 1.31; 95%
CI, 1.14–1.50), men (PR, 1.12; 95% CI, 1.01–1.23), and older
patients (PR, 1.08; 95% CI, 1.05–1.12 per 10-year increase in
age) were more likely to present late. Over the 11-year time
period, a decreasing proportion of black and white patients
entered care with CD4 counts ,350 cells/mm3, whereas little
change was seen among Latinos (Figure 1).
A total of 279 ADEs were diagnosed#60 days after care entry
among 207 patients (24% of cohort), with a higher prevalence
among Latinos versus non-Latinos (34% vs 23%; P5 .02). Only
14 patients (1.6%) presented with an ADE and a CD4 count
.200 cells/mm3, the majority of which were due to esophageal
candidiasis (43%) and Kaposi’s sarcoma (22%). Overall, 7%
of the cohort had $2 ADEs (10.3% of Latinos vs 6.2% of
non-Latinos; P 5 .13). Pneumocystis jiroveci infection was the
most frequently reported ADE, and Latinos had the highest
prevalence (13.4%) (Figure 2). Latinos accounted for the majority
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and histoplasmosis (3 of 4), although the overall reported
numbers were small. Prevalence of active tuberculosis on entry
was 6.2% for Latinos.
DISCUSSION
Significant clinical differences existed on first presentation to
HIV care among Latinos versus both non-Latino black and
white patients in our clinic cohort located in the southeastern
United States. Latino participants were younger, yet they had
significantly lower median CD4 cell counts, which were most
pronounced among men. Moreover, Latinos were more likely
to present with specific ADEs and were 1.4 times more likely
than non-Latinos to present with a CD4 count,350 cells/mm3
or an ADE, after controlling for other factors, including age,
sex, and year entering care. No statistically significant clinical
differences at HIV care entry were seen between black and
white patients. In addition to Latino ethnicity, we found that
older age and male sex were independently associated with late
presentation. To our knowledge, our study is the first detailed
description of differences among ethnic groups in a non-
traditional Latino settlement area in the southeastern United
States, a region with the largest number of US persons living
with AIDS and a substantial proportion of HIV-infected per-
sons residing in nonurban areas [17].
Although many studies have not observed significant im-
munologic differences between racial/ethnic groups at entry to
care or diagnosis [4, 18–20], other investigators have reported
similar findings of lower CD4 counts among Latinos [21, 22].
Only one of these focused on nontraditional Latino settlements;
the other examined immigrant-rich areas. Among patients en-
tering care from 1996 to 2001 in Nebraska, a nontraditional
Latino settlement area, Latinos had lower median CD4 counts,
compared with both white and black persons (220 vs 372 and
318 cells/mm3, respectively), and were more likely to have an
Table 3. Predictors of Presenting to HIV Care Between 1999 and 2009 With a CD41 Cell Count <350 Cells/mm3 or an AIDS-Defining Event
Variable Unadjusted PR (95% CI) P Adjusted PRa (95% CI) P
Race/ethnicity
Latino 1.35 (1.15–1.58) ,.001 1.31 (1.14–1.50) ,.001
Black 1.03 (.90–1.18) .65 1.01 (.92–1.12) .78
White Referent Referent
Age, per 10-year increase 1.11 (1.07–1.15) ,.001 1.08 (1.05–1.12) ,.001
Sex
Male 1.18 (1.04–1.35) .01 1.12 (1.01–1.23) .03
Female Referent Referent
Transmission risk group
MSM 0.90 (.80–1.01) .08 NA
Non-MSM Referent NA
Distance, per 16 km (10 miles) 1.01 (.99–1.02) .28 NA
Residence
Small/isolated rural 1.15 (.96–1.38) .12 NA
Large rural 1.06 (.94–1.20) .32 NA
Urban Referent NA
Year entering care NA
1999–2001 1.28 (1.11–1.47) ,.001 1.14 (1.02–1.27) .02
2002–2005 1.14 (.98–1.33) .09 1.09 (.97–1.22) .16
2006–2009 Referent Referent
NOTE. CI, confidence interval; MSM, men who have sex with men; NA, not applicable; PR, prevalence ratio.
a Based on a log-linear binomial regression model including race/ethnicity, age, sex, and year entering care.
Figure 1. Proportion of patients by race/ethnicity presenting with
CD41 cell counts ,350 cells/mm3 by time period entering care.
Categorized by CD41 cell count distribution.
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opportunistic infection [21]. In 5 US clinics along the Mexican
border, a location with an increasing HIV incidence and migrant
population, the median CD4 counts at entry were lower for
Latinos than non-Latinos (246 vs 376 cells/mm3) [22]. At 2 of
these clinics, Latinos were twice as likely to present with AIDS
after adjusting for age, sex, and mode of exposure. Although
both of these studies included antiretroviral therapy–naive pa-
tients, they did not restrict to patients initiating HIV care. De-
spite our use of more recent data, we observed even lower CD4
counts among Latinos compared with both these studies. In
addition, we found no effect of rural residence and distance to
care on late presentation—variables that were not examined in
these prior studies among Latinos. Finally, the substantial age
difference between Latinos and non-Latinos in our study was
not similarly described.
The primary factor driving our findings of lower CD4 counts
among Latinos may be a large number of foreign-born Latinos.
An estimated 53% of Latinos in North Carolina are foreign
born, compared with 38% in the United States in general
[8]. Prior studies that did not find significant immunologic
differences among racial/ethnic groups were often characterized
by smaller sample sizes [18, 20] or perhaps included Latinos
from both immigrant-rich and US-born populations [4, 19, 23].
In a study from northern California that included a large im-
migrant population comprising mostly Latinos, immigrant
status but not Latino ethnicity was the only factor in-
dependently associated with an opportunistic infection at di-
agnosis [23].
The immigrant-rich nature of the North Carolina Latino
population is reflected in its younger age structure [6] and
certain clinical characteristics found in our study. We found that
Latinos accounted for 86% of active tuberculosis cases among all
patients initiating HIV care. Foreign-born persons with HIV are
at risk of reactivating opportunistic infections endemic to their
originating countries, such as tuberculosis. Nationally, Latinos
comprised 23% of tuberculosis cases among HIV-infected in-
dividuals in 2005 [24]. Surveillance data from southern Cal-
ifornia showed that Latinos accounted for 82% of cases of
concurrent HIV infection and tuberculosis in 2007, compared
with 42% in 1993, a change attributed to an increase in cases in
Mexican-born immigrants [25]. In addition, the majority of
histoplasmosis cases in our study occurred among Latinos,
which also is indicative of migration, because histoplasmosis is
not endemic to North Carolina.
Initial entry to medical care in the later stages of HIV disease
may either be due to a delay in diagnosis or a delay in accessing
care. Factors associated with delays in seeking medical care after
HIV testing may differ from factors associated with late testing
[26]. We found that .80% of white and Latino persons and
.75% of black persons who entered care with an AIDS
Figure 2. AIDS-defining events diagnosed at presentation to care by race/ethnicity. Figure represents total number of cases and overall prevalence (%)
within each race/ethnicity. *Other conditions include coccidioidomycosis (n5 1), chronic cryptosporidiosis (n5 3), chronic herpes simplex ulcers (n5 1),
recurrent pneumonia (n 5 1), progressive multifocal leukoencephalopathy (n 5 3), and recurrent Salmonella septicemia (n 5 1).
HIV/AIDS d CID 2011:53 (1 September) d 485
diagnosis had their initial HIV positive test#6 months prior to
entering care. These observations suggest that late testing ac-
counts for the majority of late entries into care, rather than
a delay in accessing treatment, and are similar to findings in
other studies [26–28]. In a study at the Veterans Health Ad-
ministration (VA), where equal access is available, more than
one-half of the HIV-infected patients presented with AIDS,
and no difference was seen between patients who had received
prior VA health care or not, suggesting a larger contribution
from late testing [27]. A limitation of our data lies in our in-
formation on the date of the first positive HIV test result.
Although we extracted these data from multiple sources, in-
cluding North Carolina state testing data, patients might not
have disclosed previous testing in a private clinic or outside the
state.
Potential factors associated with late HIV testing have been
investigated in both Latino and non-Latino populations using
various definitions of late testing/diagnosis. Older age [5, 26, 29–
33] and male sex [5, 18, 32, 33] have been recognized as in-
dependently associated factors in several studies; this is consis-
tent with our results. Older persons may have a lower perception
of HIV risk, resulting in late testing. Foreign-born status is also
independently associated with late testing in several studies, both
in the United States and Europe [23, 29–34]. In a US surveil-
lance study of Latinos, a short interval in progression from the
initial HIV diagnosis to AIDS was also associated with birth in
Mexico or Central America, high-risk heterosexual contact, and
IDU [5]. However, among interviews of Latinos with AIDS in
Los Angeles, California, only completion of the interview in
Spanish was associated with late testing after adjusting for age,
education, country of birth, and IDU status [35]. Thus, accul-
turation factors, such as English proficiency, may be a principal
barrier to late testing for immigrant Latinos.
Notably, heterosexual risk was the predominate mode of
transmission reported among Latinos in our study, but only
24% of subjects were Latina. This finding may indicate under-
reporting of MSM risk due to the high rate of social stigma
surrounding homosexuality among Latinos [36, 37]. Alterna-
tively, the higher proportion of men in our study may reflect the
demographic structure of the immigrant Latino population in
North Carolina, which is majority male [38]; these men may
have female partners residing in their originating countries.
We lack specific migration history on our Latino patients,
preventing direct assessment of the effect of immigration on
HIV clinical characteristics and entry to care. Gathering these
data, as well as information on acculturation markers, such as
language, alcohol and substance abuse, sexual partnerships, in-
surance, and legal status, may offer further insight into reasons
for delayed entry to care among Latinos. This knowledge would
be instrumental in informing targeted intervention programs
not only in North Carolina but also potentially in other
nontraditional Latino settlement areas. Given the high rates of
late presentation seen among all groups in our cohort, there
clearly is a continued need for a comprehensive public health
program focusing on early testing for everyone, as well as for
understanding the barriers between Latino immigrants and full
use of public health resources.
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